This audio program discusses DSM-5 classification of anxiety and related disorders, antipsychotic use in breast cancer patients, and adult outcomes of disruptive mood dysregulation disorder. Treatment trials for a parental intervention aimed at preventing antisocial personality and family-focused treatment plus medication for adolescents with bipolar disorder are also examined. The issue also looks at Internet-delivered treatment for substance abuse, virtual reality therapy for PTSD in conjunction with either D-cycloserine or alprazolam, and treatment with a synthetic neuro-active steroid via aerosol nasal spray for women with social anxiety disorder. Articles can be viewed online at www.ajp.psychiatryonline.org.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
#2425 - Ethan Hawke
11 Dec 2025
The Joe Rogan Experience
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View